BEVERLY, Mass. — Medicinal Genomics Corp. (MGC), a pioneer in harnessing genomics to improve agricultural productivity, safety, and transparency of medicinal plants, today announced its hosting of CannMed 2022, the industry’s premier science conference, May 3-5 at the Pasadena Convention Center, Pasadena CA. The greatly anticipated live in-person event will feature 60 cannabis thought leaders, scientists, physicians, and advocates from around the world who will share the latest advances in medicinal plant therapeutics.
“Once again, CannMed has emerged as the forum for introducing the latest advances in medicinal plant science, and we are honored that so many of the greatest minds in our field have chosen to share their groundbreaking work at CannMed,” said Brendan McKernan, Medicinal Genomics CEO. “Through the past difficult three years, cannabis businesses were deemed essential. That has never been truer than it is today, and the work presented here proves it. Get ready for another giant leap forward in realizing the bright future we all see for this industry.”
The list of speakers is headlined by a virtual appearance by Dr. Raphael Mechoulam, the father of cannabis research. In addition to Dr. Mechoulam, CannMed 2022 Keynote Speakers include CannMed Advisory Board Members Bonni Goldstein, MD Medical Director, Canna-Centers, and Ethan Russo, MD Founder/CEO of CReDO Science, as well as Seth Crawford, PhD Co-Founder, OregonCBD, and Grace Bandong, Scientific Strategy Leader Contaminants, Eurofins Food Integrity and Innovations.
The entire 2022 program consists of sixty presenters, each selected through a rigorous abstract submission process, whose submissions were vetted by an independent advisory board. Presenters’ expertise is divided into four broad categories: Science, Medicine, Safety and Cultivation. A complete list of CannMed’s confirmed speakers and Advisory Board members can be found here.
CannMed 2022 also includes an option for healthcare professionals to earn continuing medical education credits (CMEs) with a day-long program. More information, a conference schedule, and videos of previous CannMed conferences, can all be found at https://cannmedevents.com/.
About Medicinal Genomics Corporation
Medicinal Genomics Corporation is a pioneer in leveraging genomics to build a stronger scientific foundation for cultivating medicinal plants and their extracts. The company’s unmatched expertise in genetic science helps cultivators, dispensaries and testing laboratories characterize, understand and ensure the safety, quality and consistency of their products so patients and consumers can have confidence in what they’re buying. To support their mission, Medicinal Genomics also produces CannMed, an annual gathering of cannabis leaders dedicated to the scientific advancement of the industry. For more information, please visit http://www.medicinalgenomics.com.
